![BusinessWire - Celgene Corporation (CG3) FDA Grants Approval of IDHIFA®, the First Oral Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH2 Mutation | ResearchPool BusinessWire - Celgene Corporation (CG3) FDA Grants Approval of IDHIFA®, the First Oral Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH2 Mutation | ResearchPool](http://mms.businesswire.com/media/20170801006281/en/604221/4/AML_infographic_8117---FINAL.jpg)
BusinessWire - Celgene Corporation (CG3) FDA Grants Approval of IDHIFA®, the First Oral Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH2 Mutation | ResearchPool
![BusinessWire - Viacom Inc. Class B (VIAB) Paramount Pictures Chairman CEO Jim Gianopulos to Participate in Bank of America Merrill Lynch 2017 Media, Communications and Entertainment Conference | ResearchPool BusinessWire - Viacom Inc. Class B (VIAB) Paramount Pictures Chairman CEO Jim Gianopulos to Participate in Bank of America Merrill Lynch 2017 Media, Communications and Entertainment Conference | ResearchPool](http://mms.businesswire.com/media/20170901005516/en/609985/4/3029547_PAR_A_VIA_Co.jpg)
BusinessWire - Viacom Inc. Class B (VIAB) Paramount Pictures Chairman CEO Jim Gianopulos to Participate in Bank of America Merrill Lynch 2017 Media, Communications and Entertainment Conference | ResearchPool
![BusinessWire - YOUZU Interactive Co. Ltd. Class A (002174) Why We Call Legacy of Discord - Furious Wings the Ultimate ARPG | ResearchPool BusinessWire - YOUZU Interactive Co. Ltd. Class A (002174) Why We Call Legacy of Discord - Furious Wings the Ultimate ARPG | ResearchPool](http://mms.businesswire.com/media/20170222005657/en/571341/4/YOUZU-graphic.jpg)